Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

BACKGROUND Bone marrow aspirated from the iliac crest contains progenitor cells that can be used to obtain bone-healing of nonunions. However, there is little available information regarding the number and concentration of these cells that are necessary to obtain bone repair. The purpose of this study was to evaluate the number and concentration of progenitor cells that were transplanted for the treatment of nonunion, the callus volume obtained after the transplantation, and the clinical healing rate. METHODS Marrow was aspirated from both anterior iliac crests, concentrated on a cell separator, and then injected into sixty noninfected atrophic nonunions of the tibia. Each nonunion received a relatively constant volume of 20 cm(3) of concentrated bone marrow. The number of progenitor cells that was transplanted was estimated by counting the fibroblast colony-forming units. The volume of mineralized bone formation was determined by comparing preoperative computerized tomography scans with scans performed four months following the injection. RESULTS The aspirates contained an average (and standard deviation) of 612 +/- 134 progenitors/cm(3) (range, 12 to 1224 progenitors/cm(3)) before concentration and an average of 2579 +/- 1121 progenitors/cm(3) (range, 60 to 6120 progenitors/cm(3)) after concentration. An average total of 51 x 10(3) fibroblast colony-forming units was injected into each nonunion. Bone union was obtained in fifty-three patients, and the bone marrow that had been injected into the nonunions of those patients contained >1500 progenitors/cm(3) and an average total of 54,962 +/- 17,431 progenitors. The concentration (634 +/- 187 progenitors/cm(3)) and the total number (19,324 +/- 6843) of progenitors injected into the nonunion sites of the seven patients in whom bone union was not obtained were both significantly lower (p = 0.001 and p < 0.01, respectively) than those in the patients who obtained bone union. The volume of the mineralized callus measured at four months on the computerized tomography scans of the patients who had union ranged from 0.8 to 5.3 cm(3) (mean, 3.1 cm(3)). There was a positive correlation between the volume of mineralized callus at four months and the number (p = 0.04) and concentration (p = 0.01) of fibroblast colony-forming units in the graft. There was a negative correlation between the time needed to obtain union and the concentration of fibroblast colony-forming units in the graft (p = 0.04). CONCLUSIONS Percutaneous autologous bone-marrow grafting is an effective and safe method for the treatment of an atrophic tibial diaphyseal nonunion. However, its efficacy appears to be related to the number of progenitors in the graft, and the number of progenitors available in bone marrow aspirated from the iliac crest appears to be less than optimal in the absence of concentration.

[1]  W. Davros,et al.  Spine Fusion Using Cell Matrix Composites Enriched in Bone Marrow-Derived Cells , 2003, Clinical orthopaedics and related research.

[2]  R. Gustilo,et al.  OTD classic article review - Gustillo RB, Anderson JT (1976) Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses , 2002, The Journal of bone and joint surgery. American volume.

[3]  J N Beresford,et al.  Osteogenic stem cells and the stromal system of bone and marrow. , 1989, Clinical orthopaedics and related research.

[4]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[5]  J. Connolly,et al.  Development of an osteogenic bone-marrow preparation. , 1989, The Journal of bone and joint surgery. American volume.

[6]  P. Hernigou,et al.  Abnormalities in the Bone Marrow of the Iliac Crest in Patients Who Have Osteonecrosis Secondary to Corticosteroid Therapy or Alcohol Abuse* , 1997, The Journal of bone and joint surgery. American volume.

[7]  B. Cole,et al.  Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. , 1999, Clinical orthopaedics and related research.

[8]  Burwell Rg,et al.  The function of bone marrow in the incorporation of a bone graft. , 1985 .

[9]  R. Quarto,et al.  Bone progenitor cell deficits and the age-associated decline in bone repair capacity , 1995, Calcified Tissue International.

[10]  C. Boehm,et al.  Age‐ and gender‐related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  R. Midura,et al.  Connective tissue progenitors: practical concepts for clinical applications. , 2002, Clinical orthopaedics and related research.

[12]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.

[13]  S. T. Yoon,et al.  Osteoinductive Molecules in Orthopaedics: Basic Science and Preclinical Studies , 2002, Clinical orthopaedics and related research.

[14]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[15]  R. Burwell Studies in the transplantation of bone. 8. Treated composite homograft-autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. , 1966, The Journal of bone and joint surgery. British volume.

[16]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[17]  R. Burwell STUDIES IN THE TRANSPLANTATION OF BONE. VII. THE FRESH COMPOSITE HOMOGRAFT-AUTOGRAFT OF CANCELLOUS BONE; AN ANALYSIS OF FACTORS LEADING TO OSTEOGENESIS IN MARROW TRANSPLANTS AND IN MARROW-CONTAINING BONE GRAFTS. , 1964, The Journal of bone and joint surgery. British volume.

[18]  R W Jackson,et al.  Percutaneous bone marrow grafting of fractures and bony defects. An experimental study in rabbits. , 1986, Clinical orthopaedics and related research.

[19]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  J F Connolly,et al.  Autologous marrow injection as a substitute for operative grafting of tibial nonunions. , 1991, Clinical orthopaedics and related research.

[21]  K. Johnson Management of malunion and nonunion of the tibia. , 1987, The Orthopedic clinics of North America.

[22]  C. Boehm,et al.  Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume* , 1997, The Journal of bone and joint surgery. American volume.

[23]  S. Sharma,et al.  Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. , 1993, Acta orthopaedica Scandinavica.

[24]  J. Healey,et al.  Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. , 1990, Clinical orthopaedics and related research.

[25]  P. Hernigou,et al.  Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.